VOYA Investment Management
TARS icon

VOYA Investment Management’s Tarsus Pharmaceuticals TARS Stock Holding History

VOYA Investment Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$503K Sell
7,984
-8,896
-53% -$568K ﹤0.01% 1821
2026
Q1 		$1.18M Sell
16,880
-21,191
-56% -$1.48M ﹤0.01% 1408
2025
Q4 		$3.12M Buy
38,071
+6,076
+19% +$454K ﹤0.01% 1037
2025
Q3 		$1.9M Sell
31,995
-4,132
-11% -$203K ﹤0.01% 1253
2025
Q2 		$1.46M Buy
36,127
+7,207
+25% +$324K ﹤0.01% 1411
2025
Q1 		$1.49M Sell
28,920
-1,113
-4% -$55K ﹤0.01% 1421
2024
Q4 		$1.66M Buy
30,033
+18,000
+150% +$818K ﹤0.01% 1371
2024
Q3 		$396K Sell
12,033
-288
-2% -$8.1K ﹤0.01% 2130
2024
Q2 		$335K Buy
12,321
+2,767
+29% +$93K ﹤0.01% 2207
2024
Q1 		$347K Sell
9,554
-1,888
-17% -$55.5K ﹤0.01% 2178
2023
Q4 		$232K Buy
+11,442
New +$191K ﹤0.01% 2503

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

VOYA Investment Management's TARS Position: Q2 2026 in Review

VOYA Investment Management reduced its Tarsus Pharmaceuticals (TARS) stake by 53% in Q2 2026, selling an estimated $568K and leaving 7,984 shares worth $503K. The position accounts for ﹤0.01% of the portfolio, ranked #1821.

VOYA Investment Management first reported a position in TARS in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.12M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • VOYA Investment Management held 7,984 shares of Tarsus Pharmaceuticals worth $503K as of Q2 2026.
  • VOYA Investment Management sold 8,896 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $568K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1821 holding.
  • VOYA Investment Management first reported a position in Tarsus Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • VOYA Investment Management's Tarsus Pharmaceuticals position peaked at $3.12M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.